Skip to main content
Microbiology Spectrum logoLink to Microbiology Spectrum
. 2022 May 31;10(3):e02604-21. doi: 10.1128/spectrum.02604-21

Origin, Phylogeny, and Transmission of the Epidemic Clone ST208 of Carbapenem-Resistant Acinetobacter baumannii on a Global Scale

Yue Gao a,b, Henan Li b, Hongbin Chen b, Jiangang Zhang b,*, Ruobing Wang b, Zhiren Wang b, Hui Wang a,b,
Editor: Daria Van Tynec
PMCID: PMC9241911  PMID: 35638783

ABSTRACT

Carbapenem-resistant Acinetobacter baumannii (CRAB) is an opportunistic pathogen that has become a global threat. The dissemination of global clone 2 (GC2) CRAB has been well documented. Oxford sequence type (ST) 208 is one of the most prevalent lineages of A. baumannii GC2; however, its evolution and phylogeny are unclear. We collected 45 representative ST208 isolates from 14 cities in China between 1999 and 2018. Moreover, 411 ST208 genome sequences were downloaded from the GenBank database for comparison. The global ST208 phylogeny showed that ST208 might have originated from North America and subsequently evolved into two clades. Notably, the widespread OXA-23-producing ST208 A. baumannii was correlated with the transposon structure and dynamics of replicative transposition, and the Tn2009 tandem structure of five copies of blaOXA-23 and potential circular intermediate of Tn2009 were first detected. Furthermore, 15 Chinese ST208 isolates carried GR25 pABTJ1-like plasmids, which contained blaOXA-23 and have only been found in China in the last decade. In conclusion, our work suggests that replicative transposition contributes to the evolution and transmission of OXA-23-producing ST208 A. baumannii and highlights the new challenges posed by the epidemiological surveillance of globally distributed clonal groups via whole genome sequencing.

IMPORTANCE ST208 as one of the most prevalent lineages of CRAB has caused several difficult-to-treat infections and outbreaks around the world. However, few studies have focused on evaluating the genetic background differences of ST208 A. baumannii isolated from very distant geographic regions. A comprehensive genomic analysis of 456 clinical strains of ST208 A. baumannii from a wide temporal and geographic range was performed in this study. Moreover, the mechanisms leading to the horizontal transfer of blaOXA-23 in ST208 A. baumannii are poorly understood. We first describe experimental evidence of the potential circular intermediate of Tn2009, and the Tn2009 tandem structure of five copies of blaOXA-23 was first detected. The interbacterial transfer of genetic elements carrying resistance to last-line antibiotic carbapenems highlights the essential need to enhance epidemiologic surveillance.

KEYWORDS: Acinetobacter baumannii, ST208, whole genome sequencing (WGS), genome epidemiology

INTRODUCTION

Acinetobacter baumannii has emerged as an opportunistic pathogen that has caused difficult-to-treat infections. Since the 1970s, it has spread rapidly across hospitals worldwide. Generally, A. baumannii is frequently involved in ventilator-associated pneumonia, wound infections, urinary tract infections, and bacteremia (1). These infections occur in hospitalized patients who have had significant contact with the health care system, especially in intensive care units (2). With a strong capacity for clonal transmission and the acquisition of antimicrobial resistance determinants, approximately 45% of global A. baumannii isolates are considered multidrug-resistant (MDR) (3). Outbreaks caused by MDR A. baumannii have been reported around the world. GC1 and GC2 are two major clones responsible for most of these outbreaks (4).

Clonal complex 208 (CC208), corresponding to GC2, is one of the largest clonal complexes of A. baumannii, which includes ST195 and ST208. CC208 often carries carbapenemase resistance genes such as blaOXA-40-like, blaOXA-58-like, and blaOXA-23-like and the carbapenem resistance rate of CC208 is significantly higher than that of the non-CC208 group (1). ST208 A. baumannii was first detected in Australia in 1999 (5), and isolates were subsequently found in the United States and other European and Asian countries (69). In recent years, ST208 has become one of the predominant sequence types (STs) of carbapenem-non-susceptible isolates in China (1012). Several outbreaks of MDR ST208 A. baumannii producing OXA-23-like carbapenemase have occurred (1315), representing a serious public health threat. However, few studies have focused on evaluating the genetic background differences and worldwide dissemination of ST208 A. baumannii isolated from very distant geographic regions.

Recently, a study showed that neither the Oxford scheme nor the Pasteur scheme accurately reflects the relationships among A. baumannii isolates, especially for ST208 A. baumannii, and owing to the high levels of recombination events, ST208 could be divided into distinct lineages when employing cgMLST and cgSNP (16). However, the decrease in whole genome sequencing (WGS) costs would make this powerful genotyping strategy an ideal tool for analyzing A. baumannii with highly dynamic genomes (16). To increase our understanding of the genomic epidemiology, phylogenetic diversity, and evolution of ST208 A. baumannii, a comparative genomic analysis of 456 ST208 A. baumannii isolates recovered from 20 countries was performed.

RESULTS

Characteristics of ST208 A. baumannii in China.

According to our previous study (1999 to 2005) (17), the Chinese Antimicrobial Resistance Surveillance of Nosocomial Infections (CARES) (2007 to 2016) (18), and the Chinese Meropenem Surveillance Study (CMSS) (2010 to 2018) (19), we investigated the non-duplicate and clinically significant isolates from bloodstream infections, hospital-acquired pneumonia, and intra-abdominal infections from 1999 to 2018 in China prioritizing MDR A. baumannii and isolates mainly from blood, as well as from the respiratory tract. Then, 292 representative isolates consisting of 34 predominant clones in 13 cities of China and from different dates and sources were sequenced. In total, 45 ST208 A. baumannii isolates were selected in this study, consisting of two isolates from 2005, 10 isolates from CARES (2007 to 2016), and 33 isolates from CMSS (2010 to 2018), representing northern, eastern, central, and southern regions throughout China. Most of them were isolated from blood (25/45, 55.6%) and sputum (12/45, 26.7%).

Phylogeny analysis of ST208 in a global context.

For global phylogenetic analysis, 411 ST208 A. baumannii genome sequences with time data were downloaded from GenBank representing diverse geographical locations, including Australia (n = 2), Canada (n = 9), China (n = 177), Czech Republic (n = 1), Denmark (n = 2), France (n = 1), Germany (n = 3), Greece (n = 4), India (n = 3), Iraq (n = 1), Japan (n = 2), Mexico (n = 2), Pakistan (n = 7), Saudi Arabia (n = 2), Singapore (n = 1), South Korea (n = 11), Spain (n = 12), Switzerland (n = 3), Thailand (n = 7), the United States (n = 189), and unknown (n = 17) (Table S1). Capsular polysaccharides (CPSs) play an important role in enhancing resistance to disinfection and long periods of desiccation and contribute to the successful persistence of A. baumannii in the hospital environment (20). Capsule (K antigen) and/or O-antigen surface polysaccharides are major virulence determinants that protect A. baumannii from complement-mediated phagocytosis. The composition and structure of K antigens can vary considerably between different strains of the same species (21). The K types of 456 ST208 isolates were identified by adopting the Kaptive program in our study. KL2 was the most predominant K type, which is extensively found in North and Central America, Asia, Oceania, and Europe. As previously described, KL2 often occurs in antibiotic-resistant GC2 isolates from different sources and is geographically widely distributed (21, 22). Furthermore, KL7 and KL28 were only found in China, and KL9 was only found in some isolates from Canada and one isolate from South Korea (Fig. 1).

FIG 1.

FIG 1

Geographic distribution of 456 ST208 Acinetobacter baumannii isolates involved in this study. Pie charts are colored based on the K type of the isolates.

After excluding recombinant regions, a maximum-likelihood phylogenetic tree of all 456 ST208 A. baumannii genome sequences was then constructed (Fig. 2). The global ST208 phylogeny showed that ST208 might have originated from North America and subsequently evolved into two clades; most of the isolates from North America accumulated in one clade, and the other clade included isolates mainly from Asia, highlighting within-ST diversity. The close evolutionary relationships between isolates from geographically distant regions suggested the global dissemination of ST208 A. baumannii. Across the global core genome phylogenies, we found that Chinese isolates recapitulated a sizeable proportion of the diversity observed globally (Fig. 2), suggesting multiple introductions from and into China, likely with distinct phylogeographic origins.

FIG 2.

FIG 2

Recombination-filtered core genome phylogeny and the distribution of antimicrobial resistance genes in ST208 Acinetobacter baumannii. The highlighted boxes denote the substructure within ST208 (North America subclade and China subclade). The panel on the right indicates the presence or absence of the genes (colored or blank) carried per isolate. Identical colors for the strain name indicate that they were recovered from the same geographic location.

Variation in genes related to carbapenem resistance.

All 456 ST208 isolates carried some similar antimicrobial resistance (AMR) gene profiles, such as aph(3′)-Ia and aph(6’)-Id genes, encoding aminoglycoside resistance; the tet(B) gene, conferring resistance to tetracycline. However, the two subclades revealed different AMR gene profiles (Fig. 2). Compared with China subclade, there was considerable heterogeneity in the carriage of genes conferring resistance to aminoglycosides, beta-lactams, phenicols, macrolides, chloramphenicols, and trimethoprims within North America subclade. Some isolates from North America, Europe, Middle East, Oceania, and South Asia and East Asia in North America subclade lacked the genes armA, blaOXA-23-like, catB8, mph(E), and msr(E). Phylogeny across isolates suggested that the North America subclade and China subclade share a common ancestor, and then diverged from each other. However, they have been in joint circulation, possibly due to the clinical introduction of aminoglycosides, chloramphenicols, and trimethoprims, some isolates carried aac(3′)-Ia, aac(6′)-Iaf, cmlA1, and dfrA7 (Fig. 2).

Although the short-read data produced by most currently available ST208 A. baumannii genomes are sufficient to identify antibiotic resistance genes or construct phylogenetic trees, they cannot resolve complex resistance regions (4), such as the OXA β-lactamases, which form the basis of transferable carbapenem resistance in A. baumannii (23). As numerous repeated elements in OXA resistance regions, with 387 short-read data and 69 long-read data of ST208 A. baumannii, we only detected the presence or absence of the following β-lactamase in this part. blaOXA-66 was the most common blaOXA-51-like variant in ST208 A. baumannii (381/456, 84.9%) in our study. blaOXA-23 was present in 67.8% of ST208 isolates. The context of these complex resistance regions can be determined owing to optimal sequencing and assembly using long-read sequencing technologies such as PacBio or Oxford Nanopore Technology (ONT). In the following section of the accessory genome of ST208 A. baumannii, the upstream and downstream environments of blaOXA-23 in 69 long-read data sets were analyzed.

Variation in the accessory genome of ST208.

The whole-genome repertoire of A. baumannii (the “pan genome”) is impressively large (24, 25), and as more genomes were collected, the core genome tended to become smaller and the accessory genome tended to become larger (24). The accessory genome represents an important component of the total A. baumannii genome and harbors elements that can be acquired by horizontal gene transfer. These include A. baumannii genomic resistance islands (AbGRIs), insertion sequence (IS) elements, plasmids, prophages, and transposons (25).

We analyzed 69 ST208 PacBio sequencing data sets, including those from China (n = 49), Canada (n = 9), the United States (n = 5), Australia (n = 2), South Korea (n = 2), India (n = 1), and Mexico (n = 1). All strains showed distinct accessory genomes, and the accessory genomes of ST208 from China were more diverse than those from other places as they carried more transposons, prophage regions, and plasmids (Fig. S1). Valuable information about the origin, evolution, and spread of resistance in bacterial populations is often provided by the genetic environment of antibiotic resistance genes (4). blaOXA-23 is usually associated with plasmids or is integrated through transposons into the A. baumannii chromosome. Four transposons harboring blaOXA-23 have been reported, namely, Tn2006, Tn2007, Tn2008, and Tn2009. Tn2007 possesses the ISAba4 promoter upstream of the blaOXA-23 gene and is thought to be immovable (not a transposon). Tn2006, Tn2008, and Tn2009 share a common region, “OXA-23-ΔATPase.” They also contain ISAba1. The two ISAba1 copies were inversely orientated in Tn2006 compared with being the same direction in Tn2009. Tn2006 and Tn2008 are reported globally, whereas Tn2009 has only been discovered in China (12). Of the 69 ST208 isolates, 40 carried at least one copy of blaOXA-23, and they were all located on transposons. Eleven isolates had multiple copies of blaOXA-23. In five isolates (5651, 5685, 5779, 5780, VB723), blaOXA-23 was located on Tn2006 and scattered in different locations on the chromosomes; however, in six other isolates, blaOXA-23 copies clustered together to form a Tn2009 tandem repeat structure (Fig. 3). Each of the blaOXA-23 genes was located in the same genetic context as the insertion sequence ISAba1 upstream and downstream and was bracketed by Tn2009. Two copies of ISAba1 were found to flank an internal segment that contains the blaOXA-23 gene, as well as genes encoding an AAA ATPase, hypothetical protein, ParA-like protein, YeeC-like protein, and DEAD helicase YeeB. Multiple copies of this unit were present in tandem. We hypothesized that blaOXA-23 translocation could be mediated via a circular intermediate with the assistance of the ISAba1 element. Reverse PCR was performed to detect the potential circular intermediate. PCR products with a size of ~2.3 kb were amplified from isolate 5634, which harbored only one copy of Tn2009 (Fig. 4A). Sequence analysis showed that the PCR products consisted of partial sequences of blaOXA-23, yeeB, and one complete copy of ISAba1, indicating the potential of Tn2009 to form a circular intermediate via ISAba1. After aligning this with the complete sequence of isolate 5634, we found that the ISAba1 element in the putative circular intermediate was derived from the downstream ISAba1 element, which differed from the upstream ISAba1 at the potential promoter region (upstream ISAba1: ATATTT-ISAba1, downstream ISAba1: AAAGAG-ISAba1). MICs of imipenem (IPM) and meropenem (MEM) correlated well with the expression of blaOXA-23 (Fig. 4B). However, isolate 6080, which had three copies of blaOXA-23, presented lower expression of blaOXA-23 and MICs compared with those of the other five isolates. It consisted of two complete copies and an incomplete copy of Tn2009, and another ISAba1 was located upstream of this structure, forming a “duplicate” ISAba1 (Fig. 3). Whether this structure affects the MICs of IPM and MEM and the expression of blaOXA-23 requires further investigation. A comparison of the gene-environment revealed that the tandem repeat structures were surrounded by a gene encoding the same hypothetical protein upstream and downstream. Previous studies have shown that ISAba1 is involved in the dissemination and amplification of blaOXA-23, although the Tn2009 tandem structure of five copies of blaOXA-23 and the potential circular intermediate have not been previously reported.

FIG 3.

FIG 3

Genetic context of multiple copies of blaOXA-23 from six isolates. Isolates 5740, 5761, 5767, 5840, and XH386_2 showed several copies of the Tn2009 unit present in tandem. Isolate 6080 consisted of two complete copies and an incomplete copy of Tn2009, which had three copies of blaOXA-23, and another ISAba1 was located upstream of this structure, forming a “duplicate” ISAba1.

FIG 4.

FIG 4

Formation of a potential circular intermediate by ISAba1. (A) Genetic structure of transposon Tn2009 (located in the chromosome of isolate 5634) and its potential circular intermediate. Gel electrophoresis of PCR amplicons corresponding to the circular intermediate of Tn2009, detectable in isolate 5634 using the reverse primers CIR-F and CIR-R. (B) MICs of imipenem (IPM) and meropenem (MEM) and the expression of blaOXA-23 in the six isolates. Isolate 6080 presented with lower expression of blaOXA-23 and MICs compared with those of the other five isolates.

AbaR-type islands are mainly found in the A. baumannii GC1 clone, and AbGRI1-type and AbGRI2-type islands occur mainly in A. baumannii GC2 isolates. As complex class III transposons, the AbGRI islands are located in the comM gene, with a set of tniC–tniA–tniB–tniD–tniE transposition genes in this location. AbGRI1 has a complex origin with various combinations of transposon Tn6022 (orf4-sup-uspA-orf-tniE-tniD-tniB-tniA-tniC), a deletion derivative Tn6022Δ, a defective transposon Tn6172, strA-strB (streptomycin resistance), tetA(B) (tetracycline resistance), or blaOXA-23 from Tn2006 (26). Interestingly, in our collection, except WM99c (isolated from 1999), all 68 genomes lacked sul2 for sulfonamide resistance in AbGRI1 compared with the reference sequence A91 (GenBank accession number JN968483); however, sul2 was still present in several ST208 A. baumannii genomes, suggesting that they might be found in other locations on their chromosomes.

Comparison of ST208 plasmids.

We used 18 ST208 A. baumannii complete plasmid sequences deposited in NCBI as of December 15, 2020, and obtained 58 plasmids from our 45 isolates to increase the plasmid diversity included in our study. In total, our study comprised 76 plasmids of various sizes, ranging from 8,763 to 112,157 bp (Table S2). Moreover, our plasmid collection originated from 67 different isolates and five countries, each carrying up to three plasmids. In 2010, Bertini et al. made a classification system for A. baumannii plasmids based on the nucleotide identity of rep genes (27). In our study, the rep gene was compared with representatives of each group (GR) categorized by A. baumannii PCR-based replicon typing (AB-PBRT) using BLASTn to identify its closest matches. Among the 76 plasmids in our collection, 74 had an intact rep gene, including GR24 (n = 33), GR25 (n = 15), GR6 (n = 13), GR8 (n = 10), GR2 (n = 2), and GR26 (n = 1). Nevertheless, in plasmids p5741_1 and pORAB01-2, we could not find a Rep protein via BLAST searches or annotation (Table S2).

The general structure of each plasmid group was very stable, even though some of the plasmids were isolated many years ago (28). As a representative plasmid of GR24, pABTJ2 was a 110,967 bp plasmid and contained many genes that normally form the chromosomes of bacteria or bacteriophages, such as polA, dnaN, nrdA, and nrdB, related to DNA metabolism and replication, which are speculated to improve replication function under stressful conditions. Several genes encoding phage proteins were scattered in the last 30 kb region of pABTJ2. These genes have been isolated and proposed to be phage remnants and encode proteins related to packing/morphogenesis and host lysis (29). In our study, 33 GR25 members were almost identical and shared very similar gene contents and organization. The oldest member of this group was pWM99c-2, isolated in 1999, and the most recent was p5846, isolated in 2018 (Fig. 5A). The presence of structurally nearly identical plasmids isolated from geographically widespread regions indicates the global dissemination of this type of stable plasmid in ST208 A. baumannii isolates.

FIG 5.

FIG 5

Comparative analyses of ST208 Acinetobacter baumannii plasmids. (A) Circular map of GR24 plasmids of ST208 A. baumannii. A cluster of genes encoding phage proteins is indicated in the outermost circle. Thirty-three plasmids with similar sequence organizations were aligned against pABTJ2 (GenBank accession number NC_020524). (B) Circular map of GR25 plasmids of A. baumannii ST208. Resistance determinants and type IV secretion systems are indicated in the outermost circle. Fifteen plasmids with similar sequence organizations were aligned against pABTJ1 (GenBank accession number CP003501).

Similarly, as a representative plasmid of GR25, the plasmid pABTJ1 was determined to be a 77 ,528 bp circular plasmid and harbored transposon Tn2009, flanked by two ISAba1 elements, transcribed in the same direction (30). pABTJ1 was isolated in 2012, and the sequences of 15 plasmids showed 99% identity to pABTJ1 (Fig. 5B); however, pABTJ1 was not the first GR25 plasmid to carry OXA-23 in China. According to our study, p5773 and p5729 were isolated as early as 2010. The blaOXA-23 gene located on a putatively conjugative plasmid might contribute to the dissemination of carbapenem resistance in this strain, and thus, it might have contributed to a wide host range in China over the last decade.

In general, the main types of plasmids in ST208 A. baumannii are GR24 and GR25. The GR24 pABTJ2-like plasmid has appeared in ST208 since 1999 and has been structurally stable, similar, and related to improving the replication functions of ST208 A. baumannii under stressful conditions. The GR25 pABTJ1-like plasmid was a newly discovered plasmid carrying blaOXA-23 in the last decade and has only been found in China to date, requiring surveillance of its further spread.

DISCUSSION

Although cases of community-acquired infections have been reported, A. baumannii is undoubtedly related to hospital-acquired infections, mostly among immunocompromised patients of intensive care units. A. baumannii is primarily associated with ventilator-associated pneumonia, wound infections, urinary tract infections, and catheter-related bloodstream infections (31). It has been reported that ST208 and ST195 are the predominant epidemic types of MDR A. baumannii in China. According to our study, ST208 strains have been isolated from inpatients in several provinces of China since 2005. It is thought to be one of the most prevalent and widely distributed A. baumannii clones in China (15.4%, 45/292 isolates, collected from 14 cities between January 1999 and December 2018).

Owing to the high genome variation in A. baumannii, MLST schemes are probably not the best genotyping method (32). To assess the genetic relationship more accurately, we established a phylogenetic relationship among A. baumannii strains based on core genes. The close evolutionary relationships between isolates from geographically distant regions suggested the global dissemination of ST208 A. baumannii. The presence of some Chinese ST208 isolates in the North America subclade and vice versa further supports the spread of ST208 between continents. Phylogenetic analysis indicated that ST208 might have originated from North America and that it split into the North America subclade and China subclade. Possibly due to the clinical use of aminoglycosides, chloramphenicols, and trimethoprims, ST208 acquired extensive pan-genome diversity.

The OXA-type enzyme with potent carbapenemase activity was first described in 1985; it was a plasmid-encoded enzyme named ARI-1 and later named blaOXA-23. However, in recent decades, this enzyme type has typically contributed to carbapenem resistance in A. baumannii worldwide through horizontal gene transfer (33). Previous studies have shown that blaOXA-23 is the most common carbapenemase resistance gene in A. baumannii in China (34). blaOXA-23 was detectable in all 45 ST208 isolates in our study. Its expression is regulated by upstream promoters ISAba1 (35). The blaOXA-23 gene was found to be located on chromosomes and/or the plasmids and was associated with four different genetic structures, including Tn2006, Tn2007, Tn2008, and Tn2009 (36). However, the horizontal transfer of these structures is poorly understood. In our study, multiple copies of blaOXA-23 clustered together to form a Tn2009 tandem repeat structure, which was thought to form a circular intermediate to facilitate the dissemination of blaOXA-23. The co-existence of five copies of blaOXA-23 has not been previously reported. In addition, we found that 13 ST208 isolates from China carried the blaOXA-23 gene on GR25 pABTJ1-like plasmids and might be transferred horizontally to other species. Infection control measures and the rapid identification of blaOXA-23 should be reinforced to reduce the spread of ST208 A. baumannii.

WGS remains the most powerful solution for global surveillance of genome epidemiology (37). Expanding the use of long-read sequencing will provide a better understanding of the mobile antibiotic resistance elements and their broader contexts. Completing genome and plasmid assemblies will facilitate the characterization of novel transposons and plasmids, also providing further knowledge regarding the widespread and significant horizontal gene transfer mechanisms. However, genomic sequence data from public databases without associated phenotypic data greatly limit the potential for the reuse of genomic sequence data to address further questions. Moreover, before WGS can be routinely employed for outbreak investigations, numerous simulations and optimizations should be conducted to make it more helpful and essential for surveying A. baumannii outbreaks.

MATERIALS AND METHODS

Bacterial isolates and antimicrobial susceptibility testing.

All 292 Chinese A. baumannii isolates were selected to cover wide temporal and geographic ranges and were characterized by both antibiotic resistance phenotypes and MLST according to the Oxford scheme (http://pubmlst.org/abaumannii/) (38). From this collection of isolates, 45 ST208 isolates were involved in this study. For global phylogenetic analysis, 411 total ST208 A. baumannii genome sequences were downloaded from GenBank, with other information, including time data, the isolation source, and geographical origins. MICs were determined using the broth microdilution method, and results were interpreted according to the standards of the Clinical and Laboratory Standards Institute (CLSI) 2021-M100 (http://www.clsi.org). Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used for quality control.

Whole-genome sequencing, assembly, and annotation.

DNA from 45 ST208 isolates was isolated using a DNA purification kit (Qiagen). All isolates were subjected to WGS on the Pacific Biosciences (PacBio) Sequel platform and Illumina NextSeq 550 platform with 150-bp paired-end protocols. Libraries were prepared according to the manufacturer’s instructions. Hybrid assembly was performed using Unicycler (v0.4.6) (39) and annotated using Prokka (v1.12) (40).

Phylogenetic analysis.

Conserved core genes among the ST208 isolates were analyzed using Roary (v3.11.2) (41) with a BLASTp percentage identity of 95 %. Possible recombination events were detected with ClonalFrameML (v1.2) (42) and Gubbins (v2.2.0) (43) and then removed. Maximum-likelihood phylogenetic trees were constructed using RAxML (v8.2.10) with a general time-reversible model and 1,000 bootstrap replicates (44). and the final tree was illustrated using the R ggtree package.

Genome profiling.

Antimicrobial resistance genes were identified with ABRicate (v0.8.7) with the ResFinder database (45). The ISs were identified using the IS Finder database (http://www-is.biotoul.fr/) (46). The locus encoding proteins responsible for biosynthesis and export (K locus) and the locus for outer core biosynthesis (OC locus) of CPS were identified with Kaptive (v0.7.0) (47). Phage-associated regions were identified using PHASTER (http://phaster.ca/) (48). We obtained the complete plasmid sequences of the 45 isolates using the PacBio RSII and Illumina NextSeq platforms. Relevant plasmids were searched in the NCBI nucleotide and plasmid databases. All complete plasmids of ST208 A. baumannii available in the RefSeq and GenBank databases before December 15, 2020, were downloaded. Functional annotation was performed using RAST v2.0 (https://rast.nmpdr.org/rast.cgi) (49). Plasmid sequences were compared using BLASTn and illustrated using BLAST Ring Image Generator (BRIG) (50).

Detection of potential circular intermediates of Tn2009.

Reverse PCR (CIR-F, 5′-TATTTGCGCGGCTTAGAGCA-3′, and CIR-R, 5′-ATCGTTAGTGTTCCTGGCGG-3′; annealing temperature 56°C; amplicon size 2318 bp) was performed to investigate the potential of the ISAba1 segment to circularize. The PCR product was then sequenced by Sanger sequencing.

Determination of blaOXA-23 expression.

The expression levels of blaOXA-23 were analyzed by reverse transcription quantitative PCR (RT-qPCR) with specific primers (OXA23-F, 5′-TGACCTTTTCTCGCCCTTCC-3′, OXA23-R, 5′-TGCTCTAAGCCGCGCAAATA-3′, rpoB-F, 5′-CATTGGTGCCGCATAAGTCG-3′, and rpoB-R 5′-CTCCAAGCCGCATTTCGTTC-3′). Briefly, bacteria were grown in LB broth until mid-log phase. DNase-treated RNA templates were prepared using the Qiagen RNeasy minikit. cDNA was generated from total RNA using random primer hexamers. Dilutions of cDNA were used to quantify the level of blaOXA-23 by RT-qPCR, performed on an Applied Biosystems (ABI) 7500 real-time PCR system with a SYBR green PCR master mix (TaKaRa). The housekeeping gene rpoB was used for the calculation of relative expression.

Data availability.

All 45 complete genome sequences were deposited in the National Center for Biotechnology Information (NCBI) database. 40 newly uploaded genomes are available with the BioProject accession number PRJNA789460 and for 5 previously uploaded genomes can be found at GenBank under the accession numbers CP059354 (5662), CP082225 (p5662), CP059353 (5665), CP082892 (p5665_1), CP082891 (p5665_2), CP082893 (p5665_3), CP059352 (5678), CP082888 (p5678_1), CP082889 (p5678_2), CP082890 (p5678_3), CP079942 (5780), CP059359 (5836), CP082221 (p5836).

ACKNOWLEDGMENTS

This work was supported by the National Natural Science Foundation of China (project no. 81991533).

Y.G. and H.W. conceived the study and wrote the manuscript. H.L., J.Z., and Z.W. collected bacterial isolates and clinical data. Y.G., H.C., and R.W. performed the genomic analysis. All authors read and approved the manuscript.

We declare no conflicts of interest.

Footnotes

Supplemental material is available online only.

SUPPLEMENTAL FILE 1
Supplemental material. Download spectrum.02604-21-s0001.pdf, PDF file, 0.7 MB (755.8KB, pdf)

Contributor Information

Hui Wang, Email: whuibj@163.com.

Daria Van Tyne, University of Pittsburgh School of Medicine.

REFERENCES

  • 1.Bian X, Liu X, Zhang X, Li X, Zhang J, Zheng H, Song S, Li X, Feng M. 2021. Epidemiological and genomic characteristics of Acinetobacter baumannii from different infection sites using comparative genomics. BMC Genomics 22:530. doi: 10.1186/s12864-021-07842-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. 2017. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev 30:409–447. doi: 10.1128/CMR.00058-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ. 2020. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev 33. doi: 10.1128/CMR.00181-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hamidian M, Nigro SJ. 2019. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genom 5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Nigro SJ, Wick R, Holt KE, Hall RM. 2018. Complete genome sequence of WM99c, an antibiotic-resistant Acinetobacter baumannii global clone 2 (GC2) strain representing an Australian GC2 lineage. Microbiol Resour Announc 7. doi: 10.1128/MRA.01199-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Adams-Haduch JM, Onuoha EO, Bogdanovich T, Tian G-B, Marschall J, Urban CM, Spellberg BJ, Rhee D, Halstead DC, Pasculle AW, Doi Y. 2011. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J Clin Microbiol 49:3849–3854. doi: 10.1128/JCM.00619-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hammerum AM, Hansen F, Skov MN, Stegger M, Andersen PS, Holm A, Jakobsen L, Justesen US. 2015. Investigation of a possible outbreak of carbapenem-resistant Acinetobacter baumannii in Odense, Denmark using PFGE, MLST and whole-genome-based SNPs. J Antimicrob Chemother 70:1965–1968. doi: 10.1093/jac/dkv072. [DOI] [PubMed] [Google Scholar]
  • 8.Tada T, Miyoshi-Akiyama T, Shimada K, Shimojima M, Kirikae T. 2014. Dissemination of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan. Antimicrob Agents Chemother 58:2916–2920. doi: 10.1128/AAC.01212-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jeon H, Kim S, Kim MH, Kim SY, Nam D, Park SC, Park SH, Bae H, Lee HJ, Cho JH, Lee WK, Lee YC, Lee SH, Shin MS, Lee JC. 2018. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates from a Korean hospital that carry blaOXA-23. Infect Genet Evol 58:232–236. doi: 10.1016/j.meegid.2018.01.003. [DOI] [PubMed] [Google Scholar]
  • 10.Qu J, Du Y, Yu R, Lu X. 2016. The first outbreak caused by Acinetobacter baumannii ST208 and ST195 in China. Biomed Res Int 2016:9254907. doi: 10.1155/2016/9254907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Chen Y, Wu L, Chen Y, Xu Z, Xu L. 2016. Draft genome sequence of a multidrug-resistant blaOXA-23-producing Acinetobacter baumannii ST208 isolate from China. J Glob Antimicrob Resist 4:42–43. doi: 10.1016/j.jgar.2015.10.004. [DOI] [PubMed] [Google Scholar]
  • 12.Chen Y, Gao J, Zhang H, Ying C. 2017. Spread of the blaOXA-23-containing Tn2008 in carbapenem-resistant Acinetobacter baumannii isolates grouped in CC92 from China. Front Microbiol 8:163. doi: 10.3389/fmicb.2017.00163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Jiang L, Liang Y, Yao W, Ai J, Wang X, Zhao Z. 2019. Molecular epidemiology and genetic characterisation of carbapenem-resistant Acinetobacter baumannii isolates from Guangdong Province, South China. J Glob Antimicrob Resist 17:84–89. doi: 10.1016/j.jgar.2018.11.002. [DOI] [PubMed] [Google Scholar]
  • 14.Wang X, Du Z, Huang W, Zhang X, Zhou Y. 2021. Outbreak of multidrug-resistant Acinetobacter baumannii ST208 producing OXA-23-like carbapenemase in a children’s hospital in Shanghai, China. Microb Drug Resist 27:816–822. doi: 10.1089/mdr.2019.0232. [DOI] [PubMed] [Google Scholar]
  • 15.Jiang M, Chen X, Liu S, Zhang Z, Li N, Dong C, Zhang L, Wu H, Zhao S. 2021. Epidemiological analysis of multidrug-resistant Acinetobacter baumannii isolates in a tertiary hospital over a 12-year period in China. Front Public Health 9:707435. doi: 10.3389/fpubh.2021.707435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hua X, Zhang L, He J, Leptihn S, Yu Y. 2020. Population biology and epidemiological studies of Acinetobacter baumannii in the era of whole genome sequencing: is the Oxford Scheme still appropriate? Front Microbiol 11:775. doi: 10.3389/fmicb.2020.00775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Wang H, Guo P, Sun H, Wang H, Yang Q, Chen M, Xu Y, Zhu Y. 2007. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother 51:4022–4028. doi: 10.1128/AAC.01259-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Yin Y, Zhao C, Li H, Jin L, Wang Q, Wang R, Zhang Y, Zhang J, Wang H, Yang C, Cao B, Liu Y, Luo Y, Sun H, Wang H, Ning Y, Liu W, Liao K, Zhuo C, Zhang R, Jin Y, Hu B, Chu Y, Hu Z, Zeng J, Xu X, CARES network. 2021. Clinical and microbiological characteristics of adults with hospital-acquired pneumonia: a 10-year prospective observational study in China. Eur J Clin Microbiol Infect Dis 40:683–690. doi: 10.1007/s10096-020-04046-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Wang Q, Wang Z, Zhang F, Zhao C, Yang B, Sun Z, Mei Y, Zhao F, Liao K, Guo D, Xu X, Sun H, Hu Z, Chu Y, Li Y, Ji P, Wang H. 2020. Long-term continuous antimicrobial resistance surveillance among nosocomial Gram-negative bacilli in China from 2010 to 2018 (CMSS). Infect Drug Resist 13:2617–2629. doi: 10.2147/IDR.S253104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kenyon JJ, Hall RM. 2013. Variation in the complex carbohydrate biosynthesis loci of Acinetobacter baumannii genomes. PLoS One 8:e62160. doi: 10.1371/journal.pone.0062160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kenyon JJ, Marzaioli AM, Hall RM, De Castro C. 2014. Structure of the K2 capsule associated with the KL2 gene cluster of Acinetobacter baumannii. Glycobiology 24:554–563. doi: 10.1093/glycob/cwu024. [DOI] [PubMed] [Google Scholar]
  • 22.Hsieh YC, Wang SH, Chen YY, Lin TL, Shie SS, Huang CT, Lee CH, Chen YC, Quyen TLT, Pan YJ. 2020. Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii. Emerg Microbes Infect 9:2094–2104. doi: 10.1080/22221751.2020.1822757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Evans BA, Amyes SG. 2014. OXA beta-lactamases. Clin Microbiol Rev 27:241–263. doi: 10.1128/CMR.00117-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.McInerney JO, McNally A, O’Connell MJ. 2017. Why prokaryotes have pangenomes. Nat Microbiol 2:17040. doi: 10.1038/nmicrobiol.2017.40. [DOI] [PubMed] [Google Scholar]
  • 25.Leal NC, Campos TL, Rezende AM, Docena C, Mendes-Marques CL, de Sa Cavalcanti FL, Wallau GL, Rocha IV, Cavalcanti CLB, Veras DL, Alves LR, Andrade-Figueiredo M, de Barros MPS, de Almeida AMP, de Morais MMC, Leal-Balbino TC, Xavier DE, de-Melo-Neto OP. 2020. Comparative genomics of Acinetobacter baumannii clinical strains from Brazil reveals polyclonal dissemination and selective exchange of mobile genetic elements associated with resistance genes. Front Microbiol 11:1176. doi: 10.3389/fmicb.2020.01176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chan AP, Choi Y, Clarke TH, Brinkac LM, White RC, Jacobs MR, Bonomo RA, Adams MD, Fouts DE. 2020. AbGRI4, a novel antibiotic resistance island in multiply antibiotic-resistant Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 75:2760–2768. doi: 10.1093/jac/dkaa266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bertini A, Poirel L, Mugnier PD, Villa L, Nordmann P, Carattoli A. 2010. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother 54:4168–4177. doi: 10.1128/AAC.00542-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Salgado-Camargo AD, Castro-Jaimes S, Gutierrez-Rios RM, Lozano LF, Altamirano-Pacheco L, Silva-Sanchez J, Perez-Oseguera A, Volkow P, Castillo-Ramirez S, Cevallos MA. 2020. Structure and evolution of Acinetobacter baumannii plasmids. Front Microbiol 11:1283. doi: 10.3389/fmicb.2020.01283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Huang H, Dong Y, Yang ZL, Luo H, Zhang X, Gao F. 2014. Complete sequence of pABTJ2, a plasmid from Acinetobacter baumannii MDR-TJ, carrying many phage-like elements. Genomics Proteomics Bioinformatics 12:172–177. doi: 10.1016/j.gpb.2014.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Huang H, Yang ZL, Wu XM, Wang Y, Liu YJ, Luo H, Lv X, Gan YR, Song SD, Gao F. 2012. Complete genome sequence of Acinetobacter baumannii MDR-TJ and insights into its mechanism of antibiotic resistance. J Antimicrob Chemother 67:2825–2832. doi: 10.1093/jac/dks327. [DOI] [PubMed] [Google Scholar]
  • 31.Karah N, Sundsfjord A, Towner K, Samuelsen O. 2012. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat 15:237–247. doi: 10.1016/j.drup.2012.06.001. [DOI] [PubMed] [Google Scholar]
  • 32.Castillo-Ramirez S, Grana-Miraglia L. 2019. Inaccurate multilocus sequence typing of Acinetobacter baumannii. Emerg Infect Dis 25:186–187. doi: 10.3201/eid2501.180374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zarrilli R, Pournaras S, Giannouli M, Tsakris A. 2013. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 41:11–19. doi: 10.1016/j.ijantimicag.2012.09.008. [DOI] [PubMed] [Google Scholar]
  • 34.Ruan Z, Chen Y, Jiang Y, Zhou H, Zhou Z, Fu Y, Wang H, Wang Y, Yu Y. 2013. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int J Antimicrob Agents 42:322–328. doi: 10.1016/j.ijantimicag.2013.06.019. [DOI] [PubMed] [Google Scholar]
  • 35.Takebayashi Y, Findlay J, Heesom KJ, Warburton PJ, Avison MB, Evans BA. 2021. Variability in carbapenemase activity of intrinsic OxaAb (OXA-51-like) beta-lactamase enzymes in Acinetobacter baumannii. J Antimicrob Chemother 76:587–595. doi: 10.1093/jac/dkaa502. [DOI] [PubMed] [Google Scholar]
  • 36.Mugnier PD, Poirel L, Naas T, Nordmann P. 2010. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 16:35–40. doi: 10.3201/eid1601.090852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Reuter S, Ellington MJ, Cartwright EJ, Koser CU, Torok ME, Gouliouris T, Harris SR, Brown NM, Holden MT, Quail M, Parkhill J, Smith GP, Bentley SD, Peacock SJ. 2013. Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology. JAMA Intern Med 173:1397–1404. doi: 10.1001/jamainternmed.2013.7734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodriguez-Valera F. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43:4382–4390. doi: 10.1128/JCM.43.9.4382-4390.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Wick RR, Judd LM, Gorrie CL, Holt KE. 2017. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13:e1005595. doi: 10.1371/journal.pcbi.1005595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Seemann T. 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30:2068–2069. doi: 10.1093/bioinformatics/btu153. [DOI] [PubMed] [Google Scholar]
  • 41.Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MT, Fookes M, Falush D, Keane JA, Parkhill J. 2015. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 31:3691–3693. doi: 10.1093/bioinformatics/btv421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Didelot X, Wilson DJ. 2015. ClonalFrameML: efficient inference of recombination in whole bacterial genomes. PLoS Comput Biol 11:e1004041. doi: 10.1371/journal.pcbi.1004041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA, Bentley SD, Parkhill J, Harris SR. 2015. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res 43:e15. doi: 10.1093/nar/gku1196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Stamatakis A. 2014. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30:1312–1313. doi: 10.1093/bioinformatics/btu033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640–2644. doi: 10.1093/jac/dks261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M. 2006. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res 34:D32–6. doi: 10.1093/nar/gkj014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wyres KL, Cahill SM, Holt KE, Hall RM, Kenyon JJ. 2020. Identification of Acinetobacter baumannii loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with Kaptive. Microb Genom 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Arndt D, Grant JR, Marcu A, Sajed T, Pon A, Liang Y, Wishart DS. 2016. PHASTER: a better, faster version of the PHAST phage search tool. Nucleic Acids Res 44:W16–21. doi: 10.1093/nar/gkw387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Brettin T, Davis JJ, Disz T, Edwards RA, Gerdes S, Olsen GJ, Olson R, Overbeek R, Parrello B, Pusch GD, Shukla M, Thomason JA, 3rd, Stevens R, Vonstein V, Wattam AR, Xia F. 2015. RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes. Sci Rep 5:8365. doi: 10.1038/srep08365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Alikhan NF, Petty NK, Ben Zakour NL, Beatson SA. 2011. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 12:402. doi: 10.1186/1471-2164-12-402. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SUPPLEMENTAL FILE 1

Supplemental material. Download spectrum.02604-21-s0001.pdf, PDF file, 0.7 MB (755.8KB, pdf)

Data Availability Statement

All 45 complete genome sequences were deposited in the National Center for Biotechnology Information (NCBI) database. 40 newly uploaded genomes are available with the BioProject accession number PRJNA789460 and for 5 previously uploaded genomes can be found at GenBank under the accession numbers CP059354 (5662), CP082225 (p5662), CP059353 (5665), CP082892 (p5665_1), CP082891 (p5665_2), CP082893 (p5665_3), CP059352 (5678), CP082888 (p5678_1), CP082889 (p5678_2), CP082890 (p5678_3), CP079942 (5780), CP059359 (5836), CP082221 (p5836).


Articles from Microbiology Spectrum are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES